Laboratory Corporation of America Holdings company logo

# 1st Gen Model Laboratory Corporation of America Holdings Medical laboratories

Subscribe >> Deal exit on
Dec. 15, 2017
Deal entry on
Dec. 15, 2017
0.26%Expected margin
81.01% successful of 79 deals
$155.84 Last close price
at 14-dec-2017

LH

Model's trade recommendations 4.42% Return for period

16.95% Annual return

$15.91B Market Cap

β 0.87  

LH

Model (following trade recommendations)

LH

Underlying stock

S&P 500

Index
Return for period 4.42%
3.19%
1.78%
52wk return 14.33%
22.34%
16.82%
52wk Range
126.82—161.17
2000.54—2399.63
Sortino ratio 4.27
Sharpe ratio 2.39
Norm. RMSE 0.30%
Downside risk 3.64%
Volatility 6.51%
  • STRONG BUY Analysts consensus recommendation

Laboratory Corporation of America Holdings, an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory & end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to provide better care. It also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology & pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions, as well as laboratory testing services. Further, it provides its testing services through a sales force to the managed care organizations, biopharmaceutical companies, physicians and other healthcare providers etc.

Industry sector: Medical

Sector classification: Medical laboratories

Deep Learning based analysis and prediction model for Laboratory Corporation of America Holdings (LH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for LH model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 101M
P/E 16.80
Shares Outstanding 102M
% Held by Insiders 0.90%
% Held by Institutions 91.46%
EPS (last reported FY) $8.83
EPS (last reported Q) $2.46
EPS, estimated (last reported Q) $2.38
Total revenues $10 B
Net income $1 B